Thermo Fisher Scientific Stock News

We think that Thermo Fisher Scientific stock currently is a better pick compared to Honeywell stock stock, despite it being the more expensive of the two, trading at 6.7x trailing revenues compared to

PUNE, India, Jan. 11, 2022 (GLOBE NEWSWIRE) -- Global Next Generation Sequencing (NGS) Market is growing with a CAGR of 17.1% in the forecast period of 2022 to 2029 and is expected to reach USD 29,307.13 Million by 2029. The most appropriate, exclusive, realistic, and admirable Next Generation Sequencing (NGS) Market Research Report is delivered with devotion depending upon the business needs. With the precise base year and the historic year, estimations and calculations are performed in this industry report. Market share analysis and key trend analysis are the key accomplishing factors in this market report. Report helps to recognize how the market is going to perform in the forecast years by giving information about market definition, classifications, applications, and engagements. DBMR team provides Next Generation Sequencing (NGS) Market research report with loyalty that is promising and the way in which expected. Get Sample Report + All Related Graphs & Charts @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-next-generation-sequencing-ngs-market Key Companies operating in the Next Generation Sequencing (NGS) Market are: Agilent Technologies Inc Thermo Fisher Scientific Inc QIAGEN Illumina Inc Bio-Rad Laboratories Inc Roche Sequencing (A subsidiary of F.

Thermo Fisher Scientific Inc. (TMO) CEO Marc Casper Presents at JPMorgan 40th Annual Healthcare Conference (Transcript)

Thermo Fisher (TMO) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Thermo Fisher's (TMO) recent acquisition will boost its capabilities to serve in the high-growth cell and gene therapy market.

Thermo Fisher Scientific (TMO) closed the most recent trading day at $620.40, moving +0.3% from the previous trading session.

Here are some MedTech stocks - Quidel (QDEL), Thermo Fisher (TMO), Baxter (BAX) and BD (BDX) - that have been quite active in the acquisition front and therefore worth investor attention.

We think that Thermo Fisher Scientific stock currently is a better pick compared to 3M stock, despite Thermo Fisher Scientific trading at a more expensive valuation of 6.5x trailing revenues compared

Beat the market with dividend stocks like Toll Brothers (TOL), Microsoft (MSFT), Avery Dennison (AVY), J.B. Hunt (JBHT) and Thermo Fisher (TMO) in 2022.

Stocks like Thermo Fisher (TMO), QIAGEN (QGEN) and Quidel (QDEL) are expected to gain from increasing testing demand.

We think that Thermo Fisher Scientific Inc. currently is a better pick compared to Qualcomm Inc.. Both companies have their current P/S multiples around 6x, while TMO's current P/EBIT stands marginall

Thermo Fisher Scientific (TMO) closed the most recent trading day at $667.24, moving +0.27% from the previous trading session.